Northpond Ventures GP, LLC - Sep 14, 2021 Form 3 Insider Report for DICE Therapeutics, Inc. (DICE)

Role: 10%+ Owner
Signature: Northpond Ventures GP, LLC By: /s/ Patrick Smerkers, Senior Vice President, Finance and Operations
Stock symbol: DICE
Transactions as of: Sep 14, 2021
Transactions value $: $0
Form type: 3
Date filed: 9/14/2021, 09:25 PM
Previous filing: Jun 24, 2021
Next filing: Sep 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DICE	Series B Convertible Preferred Stock							Sep 14, 2021	Common Stock	1.74M		By: Northpond Ventures, LP	F1, F4
holding	DICE	Series C Convertible Preferred Stock							Sep 14, 2021	Common Stock	868K		By: Northpond Ventures, LP	F2, F4
holding	DICE	Series C-1 Convertible Preferred Stock							Sep 14, 2021	Common Stock	455K		By: Northpond Ventures II, LP	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Convertible Preferred Stock"), of DICE Therapeutics, Inc. (the "Issuer") will automatically convert on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock has no expiration date.
F2	All shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the "Series C Convertible Preferred Stock"), of the "Issuer will automatically convert on a one-for-one basis into shares of the Issuer's Common Stock prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Preferred Stock has no expiration date.
F3	All shares of Series C-1 Convertible Preferred Stock, par value $0.0001 per share (the "Series C-1 Convertible Preferred Stock"), of the "Issuer will automatically convert on a one-for-one basis into shares of the Issuer's Common Stock prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C-1 Preferred Stock has no expiration date.
F4	Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F5	Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.